沙特阿拉伯王国政府所属的官方政府网站。
周四 25 6月 2026
沙特官方政府网站的域名以下列后缀结尾 gov.sa
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
政府网站使用以下协议。 HTTPS 用于加密和安全。
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
| # | العنوان | التاريخ | نوع الخبر | رابط الخبر |
|---|---|---|---|---|
| 72 | SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19 | Warning | ||
| 71 | SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19 | Precautions | ||
| 70 | SFDA’s Advice on the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Patients with COVID-19 | Precautions | ||
| 77 | Safety Signal of Baricitinib and the Potential Risk of Diverticulitis | Signal | ||
| 69 | Risk of potentially fatal respiratory depression with benzodiazepines and opioids | Warning | ||
| 68 | Concern on Potential Risk of Respiratory Depression Associated with Gabapentinoids (pregabalin and gabapentin) medications | Warning | ||
| 67 | Ceftriaxone: a reminder for the risk of hypersensitivity | Warning | ||
| 66 | Concerns on paracetamol overdose in children | Warning | ||
| 65 | Risk of neuropsychiatric reactions with the use of Montelukast | Warning | ||
| 64 | Risk of Myocarditis Associated With the Use of Atezolizumab | Warning and Precaution |
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。